SC 13G Filing

Company

Syndax Pharmaceuticals Inc

Filed

December 23, 2021

Accession Number

0000897069-21-000610

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →